2024 ISPE Pharma 4.0™ and Annex 1 Conference

2024 ISPE Pharma 4.0™ and Annex 1 Conference
The submission period has ended

Call for Proposals

25 Mar 2024 - Submission Opens
20 May 2024 - Submission Deadline
28 Jun 2024 - Notifications Sent

Why attend?

2024 ISPE Pharma 4.0™ and Annex 1 Conference

The 2024 ISPE Pharma 4.0™ and Annex 1 Conference will bring together leading pharmaceutical and biopharmaceutical manufacturers, technology providers, academic scientists, and international regulators to network, share insights, and provide an outlook on digital transformation, automation, and the evolving landscape and future of Pharma 4.0™ supported Aseptic Manufacturing.

The conference will provide a leading interdisciplinary platform for all stakeholders of the pharmaceutical chain. These sessions and workshops will showcase recent innovations and trends, and directly discuss practical challenges and solutions, from a technical, logistical, and regulatory perspective. The impact of Quality Risk Management (QRM) and Contamination Control Strategy (CCS) regulations, in particular for Annex 1, will be integrated throughout the conference programme and discussions. Participants will have the opportunity to engage with industry leaders, regulators, and peers through networking events and the conference programme.

Your Conference Experience

2025 ISPE Biotechnology Conference
Expo Hall
Expo Hall
Explore groundbreaking innovations and network with industry leaders at our dynamic expo hall.
2024 ISPE Biotechnology Conference
Networking
Networking
Connect with top industry experts and expand your professional network at our exclusive networking sessions.
2025 ISPE Europe Annual Conference
Live Streams
Live Streams
Experience the conference from anywhere with our interactive live stream.
2024 ISPE Pharma 4.0™ and Annex 1 Conference
On-Demand Content
On-Demand Content
Access exclusive conference content anytime with our on-demand library for 90 days.

Conference Gallery

Receive Notifications

Stay up-to-date on registration, education opportunities, speakers, hotel discounts, exhibitor information, and more by signing up to receive notifications for the 2024 ISPE Pharma 4.0™ and Annex 1 Conference.

Name
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

International Program Committee

Vice President Vetter Development Service External Affairs
Vetter Pharma Fertigung GmbH & Co KG
International Board Liaison
Senior Director, Global Engineering & Technology
Johnson & Johnson
Vice President Strategic Development, Marketing & Communication - Partner
PQE Group
Senior Industry Advisor and Principal Consultant for Advanced Therapies
Körber Pharma Software Inc
Emerging Leader
Network Technology Robotics Lead
F Hoffmann-La Roche AG
Emerging Leader
PhD Candidate
Karlsruhe Institute of Technology (KIT)